tradingkey.logo
搜索

Allogene Therapeutics Inc

ALLO
添加自选
1.880USD
0.0000.00%
收盘 07-31 16:00美东报价延迟15分钟
460.25M总市值
亏损市盈率 TTM

ALLO 财务数据

通过专为投资者打造的一站式数据看板,全面查看 Allogene Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。

Allogene Therapeutics Inc财报日历

最新发布
5月 13, 2026
每股收益 / 预测值
-0.18/-0.19
营业收入 / 预测值
--/2.22K
报告期
FY2025 财报
营业收入(YoY)
--
-100.00%
每股收益(YoY)
-0.87
34.57%
分析师评级
BUY
2026/08/02
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
财务指标
每股收益
36.07%-0.18
39.66%-0.17
41.17%-0.19
33.36%-0.23
27.83%-0.28
44.17%-0.28
14.70%-0.32
35.30%-0.35
44.42%-0.38
22.55%-0.51
---0.37
---0.54
---0.69
---0.66
---1.67
----
----
----
----
----
营业收入
----
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-26.67%22.00K
-55.32%21.00K
-55.10%22.00K
-74.42%22.00K
-50.82%30.00K
-99.94%47.00K
0.00%49.00K
95.45%86.00K
-99.84%61.00K
--75.65M
--49.00K
--44.00K
净利润
28.67%-42.61M
35.25%-38.81M
37.55%-41.40M
23.23%-50.94M
8.10%-59.73M
30.12%-59.94M
-6.43%-66.29M
16.25%-66.36M
34.98%-65.00M
9.56%-85.78M
25.09%-62.29M
-5.94%-79.23M
-25.19%-99.97M
-110387.21%-94.85M
-6.35%-83.15M
-5.43%-74.79M
-141.86%-79.85M
100.13%86.00K
-18.11%-78.19M
-16.34%-70.94M
利润率
----
----
----
----
----
----
----
----
11.34%-295454.55%
-102.41%-408466.67%
---283122.73%
---360145.45%
---333226.67%
---201802.13%
---121318.88%
----
----
----
----
----
毛利率
----
----
----
----
----
----
----
----
0.00%100.00%
----
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
营业收入
----
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-26.67%22.00K
-55.32%21.00K
-55.10%22.00K
-74.42%22.00K
-50.82%30.00K
-99.94%47.00K
0.00%49.00K
95.45%86.00K
-99.84%61.00K
--75.65M
--49.00K
--44.00K
营业利润
29.30%-46.09M
29.90%-42.40M
26.45%-44.90M
18.07%-54.44M
6.21%-65.19M
15.83%-60.49M
3.10%-61.05M
17.50%-66.44M
29.86%-69.50M
25.43%-71.86M
23.63%-63.00M
-5.15%-80.54M
-23.88%-99.09M
-5745.81%-96.37M
-6.20%-82.49M
-7.83%-76.59M
-140.93%-79.99M
102.46%1.71M
-14.15%-77.67M
-12.46%-71.03M
净利润
28.67%-42.61M
35.25%-38.81M
37.55%-41.40M
23.23%-50.94M
8.10%-59.73M
30.12%-59.94M
-6.43%-66.29M
16.25%-66.36M
34.98%-65.00M
9.56%-85.78M
25.09%-62.29M
-5.94%-79.23M
-25.19%-99.97M
-110387.21%-94.85M
-6.35%-83.15M
-5.43%-74.79M
-141.86%-79.85M
100.13%86.00K
-18.11%-78.19M
-16.34%-70.94M
流动资产
-6.27%273.29M
-15.04%257.75M
-14.35%260.72M
-38.17%282.65M
-26.25%291.58M
-33.92%303.39M
-35.70%304.42M
-8.96%457.12M
-17.88%395.36M
-13.18%459.12M
-16.80%473.45M
-2.13%502.10M
2.50%481.46M
12.20%528.82M
13.17%569.06M
-14.80%513.03M
-34.40%469.74M
-44.23%471.32M
-41.12%502.86M
-33.80%602.17M
流动负债总额
-5.64%28.33M
-8.47%32.51M
-2.27%31.83M
-15.09%31.68M
-2.82%30.02M
-4.20%35.52M
-13.46%32.57M
-31.83%37.30M
-48.15%30.89M
-30.99%37.08M
-22.99%37.64M
21.85%54.72M
61.58%59.59M
11.53%53.73M
-8.63%48.87M
-2.37%44.91M
-32.77%36.88M
-48.92%48.17M
6.70%53.49M
12.48%46.00M
总资产
-22.05%395.96M
-24.20%415.90M
-25.35%439.77M
-27.25%470.59M
-13.37%507.98M
-14.64%548.71M
-17.30%589.12M
-16.10%646.88M
-21.49%586.35M
-21.76%642.84M
-19.74%712.33M
-18.64%770.97M
-22.57%746.87M
-20.90%821.58M
-17.76%887.57M
-15.89%947.64M
-18.19%964.63M
-15.41%1.04B
-11.72%1.08B
-10.47%1.13B
总负债
-4.49%117.08M
-2.50%123.36M
-0.74%124.44M
-4.41%126.03M
-1.92%122.59M
-3.12%126.53M
-2.98%125.37M
-10.95%131.84M
-19.16%124.98M
-15.57%130.60M
-12.46%129.22M
1.63%148.06M
41.32%154.61M
26.56%154.70M
35.05%147.61M
41.57%145.69M
0.13%109.40M
-17.53%122.23M
5.33%109.30M
8.19%102.91M
总权益
-27.64%278.88M
-30.71%292.54M
-32.00%315.33M
-33.10%344.56M
-16.47%385.39M
-17.58%422.18M
-20.47%463.75M
-17.32%515.04M
-22.10%461.37M
-23.19%512.23M
-21.20%583.10M
-22.33%622.91M
-30.75%592.26M
-27.23%666.88M
-23.71%739.96M
-21.67%801.95M
-20.06%855.23M
-15.12%916.41M
-13.30%969.94M
-12.00%1.02B
经营净额
75.60%-12.91M
24.79%-27.60M
32.70%-29.69M
38.62%-39.03M
5.31%-52.93M
31.67%-36.70M
20.56%-44.12M
-2.80%-63.59M
16.12%-55.90M
13.51%-53.71M
-16.53%-55.53M
-45.44%-61.86M
2.34%-66.64M
-36.67%-62.10M
2.50%-47.66M
-3.31%-42.53M
-38.33%-68.24M
-355.50%-45.44M
-30.04%-48.88M
-54.07%-41.17M
投资净额
-579.08%-29.59M
-38.81%33.61M
115.71%11.94M
-41.25%43.84M
-72.10%6.18M
-18.57%54.93M
-121.76%-75.99M
334.81%74.61M
-80.40%22.13M
36.02%67.46M
-237.59%-34.27M
-68.24%17.16M
604.69%112.94M
69.56%49.60M
91.39%24.91M
119.70%54.03M
-123.12%-22.38M
31.70%29.25M
115.61%13.01M
105.73%24.59M
融资净额
50.98%21.12M
36.84%7.86M
376.58%3.24M
-95.33%5.07M
747.88%13.99M
3605.16%5.74M
-84.15%679.00K
21.31%108.60M
-4.68%1.65M
236.96%155.00K
301.97%4.29M
372916.67%89.52M
-4.58%1.73M
-85.71%46.00K
-55.27%1.07M
-99.25%24.00K
-69.99%1.81M
-97.52%322.00K
-38.14%2.38M
-99.46%3.21M

常见问题

Allogene Therapeutics Inc的流动资产是多少?

根据Allogene Therapeutics Inc的FY2025财报,流动资产为257.75M(同比变化-15.04)。

Allogene Therapeutics Inc的总资产是多少?

根据Allogene Therapeutics Inc的FY2025财报,Allogene Therapeutics Inc的总资产为415.90M(同比变化-24.20)。

Allogene Therapeutics Inc的总负债是多少?

根据Allogene Therapeutics Inc的FY2025财报,Allogene Therapeutics Inc的总负债为123.36M(同比变化-2.50)。

Allogene Therapeutics Inc的总权益是多少?

根据Allogene Therapeutics Inc的FY2025财报,Allogene Therapeutics Inc的总权益为292.54M(同比变化-30.71)。

Allogene Therapeutics Inc的净营业收入是多少?

根据Allogene Therapeutics Inc的FY2025财报,Allogene Therapeutics Inc的净营业收入为-206.93M(同比变化19.63)。

Allogene Therapeutics Inc的净投资是多少?

根据Allogene Therapeutics Inc的FY2025财报,Allogene Therapeutics Inc的净投资为95.56M(同比变化26.25)。

Allogene Therapeutics Inc的净融资是多少?

根据Allogene Therapeutics Inc的FY2025财报,Allogene Therapeutics Inc的净融资为30.16M(同比变化-74.15)。

Allogene Therapeutics Inc的每股收益(EPS)是多少?

根据Allogene Therapeutics Inc的FY2025财报,每股收益(EPS)为-0.87(同比变化34.57)。

Allogene Therapeutics Inc的净利润是多少?

根据Allogene Therapeutics Inc的FY2025财报,净利润为-190.89M(同比变化25.90)。

Allogene Therapeutics Inc的股东权益回报率(ROE)是多少?

根据Allogene Therapeutics Inc的FY2025财报,股东权益回报率(ROE)为-53.42(同比变化3.12)。

Allogene Therapeutics Inc的资产回报率(ROA)是多少?

根据Allogene Therapeutics Inc的FY2025财报,资产回报率(ROA)为-39.58(同比变化8.46)。

Allogene Therapeutics Inc的营业利润是多少?

根据Allogene Therapeutics Inc的FY2025财报,营业利润为-206.93M(同比变化19.63)。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有